Amid controversy, the Independent Development Trust has appointed private contractors for oxygen plants at 55 hospitals, raising red flags about contractor qualifications and budget surges.
Following a Constitutional Court ruling, Clicks Group plans to sell its shareholding in Unicorn Pharmaceuticals, enabling new pharmacy license applications.